CAPEVAL PHARMA
My visitor profile
CAPEVAL PHARMA
Description of your activity
- From early pre-clinical to clinical development: Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals, chemicals & staff training. Complete outsourcing management services for critical studies and product development. Extensive experience in due diligence providing expert assessment of both in/out licensing. Gap anal
More information
- CapEval Pharma was founded by Dr. Olivier Loget, DVM, ERT and provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Our Strengths: • Drawing on over 60 years of combined international experience, CapEval Pharma is a team of highly qualified pharmaceutical consultants, fluent in three languages. •We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. •With experience working in Biotech, Pharma and CRO sectors, we are uniquely qualified to offer complete outsourcing management services for critical studies and product development. •We have extensive experience in due diligence proceedings (> 100) providing expert assessment of both in- and out-licensing programs and creating gap analysis, which can be used for determination of project value. •We have broad expertise in public subvention dossier, fundraising (Crédit Impôt Recherche etc) and medical writing. •We work closely with clients, to help manage key objectives and make an appropriate assessment of regulatory hurdles taking into consideration the evolving requirements of the international regulatory landscape. >100 Due Diligence projects in big pharma and biotechs 6-8 projects per year for in- or out-licensing >60 years of combined international experience
Social Networks
Emerging company
Olivier LOGET
president and CEO
Date of your company creation:
- Between 3 & 5 years
Main sector
- Biotechnology - Therapeutics and Diagnostics, Pharma
Address
- Country : FRANCE
- City : Archamps
- Zip Code : 74160
Participation objectives
Partnering objectives
- Out-licensing / collaboration opportunities, Financing / investment opportunities, Network development, Customer development
Description of my participation objective
- Supporting new projects
Communication materials
